Patient-Oriented SCORAD (PO-SCORAD): A new self-assessment scale in atopic dermatitis validated in Europe

J. F. Stalder, S. Barbarot, A. Wollenberg, E. A. Holm, L. De Raeve, S. Seidenari, A. Oranje, M. Deleuran, F. Cambazard, A. Svensson, D. Simon, E. Benfeldt, T. Reunala, J. Mazereeuv, F. Boralevi, B. Kunz, L. Misery, C. G. Mortz, U. Darsow, C. GelmettiT. Diepgen, J. Ring, M. Moehrenschlager, U. Gieler, A. Taãeb

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Background: Patient-oriented medicine is an emerging concept, encouraged by the World Health Organization, to greater involvement of the patient in the management of chronic diseases. The Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) index is a self-assessment score allowing the patient to comprehensively evaluate the actual course of atopic dermatitis (AD), using subjective and objective criteria derived mainly from the SCORAD, a validated AD severity clinical assessment tool. Objectives: To validate the PO-SCORAD index in a large European population of patients exhibiting all forms of AD severity by assessing its correlation with the SCORAD index. Patients/methods: Four hundred and seventy-one patients (185 adults, 286 children) consulting for AD in hospitals from 9 European countries were recruited. The investigators and the patients used the SCORAD and PO-SCORAD scales, respectively, to assess AD severity at inclusion (D0) and 28 ± 7 days later (D28). Results: Patient-Oriented SCORing Atopic Dermatitis and SCORAD scores were significantly correlated at D0 [r = 0.67 (95% CI: 0.62; 0.72), P <0.0001]. Consistency was confirmed at D28, with a stronger linear correlation between both scales [r = 0.79 (95% CI: 0.75; 0.83), P <0.0001]. Absolute changes from baseline in SCORAD and PO-SCORAD scores were also significantly correlated [r= 0.71 (95% CI: 0.64; 0.76), P <0.0001]. Although no specific intervention was investigated, AD improved over the study, with a decrease of PO-SCORAD and SCORAD scores from D0 to D28 by -19.19% and -24.39%, respectively. The consistency of the correlations was similar in the adult and children groups. Conclusions: This study validated the use of PO-SCORAD to self-assess AD severity and demonstrated its good correlation with SCORAD.

Original languageEnglish
Pages (from-to)1114-1121
Number of pages8
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume66
Issue number8
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Atopic Dermatitis
Self-Assessment
Chronic Disease

Keywords

  • atopic dermatitis (MesH)
  • eczema score
  • patient-oriented
  • SCORing of Atopic Dermatitis index
  • self-assessment score

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Patient-Oriented SCORAD (PO-SCORAD) : A new self-assessment scale in atopic dermatitis validated in Europe. / Stalder, J. F.; Barbarot, S.; Wollenberg, A.; Holm, E. A.; De Raeve, L.; Seidenari, S.; Oranje, A.; Deleuran, M.; Cambazard, F.; Svensson, A.; Simon, D.; Benfeldt, E.; Reunala, T.; Mazereeuv, J.; Boralevi, F.; Kunz, B.; Misery, L.; Mortz, C. G.; Darsow, U.; Gelmetti, C.; Diepgen, T.; Ring, J.; Moehrenschlager, M.; Gieler, U.; Taãeb, A.

In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 66, No. 8, 08.2011, p. 1114-1121.

Research output: Contribution to journalArticle

Stalder, JF, Barbarot, S, Wollenberg, A, Holm, EA, De Raeve, L, Seidenari, S, Oranje, A, Deleuran, M, Cambazard, F, Svensson, A, Simon, D, Benfeldt, E, Reunala, T, Mazereeuv, J, Boralevi, F, Kunz, B, Misery, L, Mortz, CG, Darsow, U, Gelmetti, C, Diepgen, T, Ring, J, Moehrenschlager, M, Gieler, U & Taãeb, A 2011, 'Patient-Oriented SCORAD (PO-SCORAD): A new self-assessment scale in atopic dermatitis validated in Europe', Allergy: European Journal of Allergy and Clinical Immunology, vol. 66, no. 8, pp. 1114-1121. https://doi.org/10.1111/j.1398-9995.2011.02577.x
Stalder, J. F. ; Barbarot, S. ; Wollenberg, A. ; Holm, E. A. ; De Raeve, L. ; Seidenari, S. ; Oranje, A. ; Deleuran, M. ; Cambazard, F. ; Svensson, A. ; Simon, D. ; Benfeldt, E. ; Reunala, T. ; Mazereeuv, J. ; Boralevi, F. ; Kunz, B. ; Misery, L. ; Mortz, C. G. ; Darsow, U. ; Gelmetti, C. ; Diepgen, T. ; Ring, J. ; Moehrenschlager, M. ; Gieler, U. ; Taãeb, A. / Patient-Oriented SCORAD (PO-SCORAD) : A new self-assessment scale in atopic dermatitis validated in Europe. In: Allergy: European Journal of Allergy and Clinical Immunology. 2011 ; Vol. 66, No. 8. pp. 1114-1121.
@article{54f341a2edc14fd9a0de3b65c635c88e,
title = "Patient-Oriented SCORAD (PO-SCORAD): A new self-assessment scale in atopic dermatitis validated in Europe",
abstract = "Background: Patient-oriented medicine is an emerging concept, encouraged by the World Health Organization, to greater involvement of the patient in the management of chronic diseases. The Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) index is a self-assessment score allowing the patient to comprehensively evaluate the actual course of atopic dermatitis (AD), using subjective and objective criteria derived mainly from the SCORAD, a validated AD severity clinical assessment tool. Objectives: To validate the PO-SCORAD index in a large European population of patients exhibiting all forms of AD severity by assessing its correlation with the SCORAD index. Patients/methods: Four hundred and seventy-one patients (185 adults, 286 children) consulting for AD in hospitals from 9 European countries were recruited. The investigators and the patients used the SCORAD and PO-SCORAD scales, respectively, to assess AD severity at inclusion (D0) and 28 ± 7 days later (D28). Results: Patient-Oriented SCORing Atopic Dermatitis and SCORAD scores were significantly correlated at D0 [r = 0.67 (95{\%} CI: 0.62; 0.72), P <0.0001]. Consistency was confirmed at D28, with a stronger linear correlation between both scales [r = 0.79 (95{\%} CI: 0.75; 0.83), P <0.0001]. Absolute changes from baseline in SCORAD and PO-SCORAD scores were also significantly correlated [r= 0.71 (95{\%} CI: 0.64; 0.76), P <0.0001]. Although no specific intervention was investigated, AD improved over the study, with a decrease of PO-SCORAD and SCORAD scores from D0 to D28 by -19.19{\%} and -24.39{\%}, respectively. The consistency of the correlations was similar in the adult and children groups. Conclusions: This study validated the use of PO-SCORAD to self-assess AD severity and demonstrated its good correlation with SCORAD.",
keywords = "atopic dermatitis (MesH), eczema score, patient-oriented, SCORing of Atopic Dermatitis index, self-assessment score",
author = "Stalder, {J. F.} and S. Barbarot and A. Wollenberg and Holm, {E. A.} and {De Raeve}, L. and S. Seidenari and A. Oranje and M. Deleuran and F. Cambazard and A. Svensson and D. Simon and E. Benfeldt and T. Reunala and J. Mazereeuv and F. Boralevi and B. Kunz and L. Misery and Mortz, {C. G.} and U. Darsow and C. Gelmetti and T. Diepgen and J. Ring and M. Moehrenschlager and U. Gieler and A. Ta{\~a}eb",
year = "2011",
month = "8",
doi = "10.1111/j.1398-9995.2011.02577.x",
language = "English",
volume = "66",
pages = "1114--1121",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Patient-Oriented SCORAD (PO-SCORAD)

T2 - A new self-assessment scale in atopic dermatitis validated in Europe

AU - Stalder, J. F.

AU - Barbarot, S.

AU - Wollenberg, A.

AU - Holm, E. A.

AU - De Raeve, L.

AU - Seidenari, S.

AU - Oranje, A.

AU - Deleuran, M.

AU - Cambazard, F.

AU - Svensson, A.

AU - Simon, D.

AU - Benfeldt, E.

AU - Reunala, T.

AU - Mazereeuv, J.

AU - Boralevi, F.

AU - Kunz, B.

AU - Misery, L.

AU - Mortz, C. G.

AU - Darsow, U.

AU - Gelmetti, C.

AU - Diepgen, T.

AU - Ring, J.

AU - Moehrenschlager, M.

AU - Gieler, U.

AU - Taãeb, A.

PY - 2011/8

Y1 - 2011/8

N2 - Background: Patient-oriented medicine is an emerging concept, encouraged by the World Health Organization, to greater involvement of the patient in the management of chronic diseases. The Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) index is a self-assessment score allowing the patient to comprehensively evaluate the actual course of atopic dermatitis (AD), using subjective and objective criteria derived mainly from the SCORAD, a validated AD severity clinical assessment tool. Objectives: To validate the PO-SCORAD index in a large European population of patients exhibiting all forms of AD severity by assessing its correlation with the SCORAD index. Patients/methods: Four hundred and seventy-one patients (185 adults, 286 children) consulting for AD in hospitals from 9 European countries were recruited. The investigators and the patients used the SCORAD and PO-SCORAD scales, respectively, to assess AD severity at inclusion (D0) and 28 ± 7 days later (D28). Results: Patient-Oriented SCORing Atopic Dermatitis and SCORAD scores were significantly correlated at D0 [r = 0.67 (95% CI: 0.62; 0.72), P <0.0001]. Consistency was confirmed at D28, with a stronger linear correlation between both scales [r = 0.79 (95% CI: 0.75; 0.83), P <0.0001]. Absolute changes from baseline in SCORAD and PO-SCORAD scores were also significantly correlated [r= 0.71 (95% CI: 0.64; 0.76), P <0.0001]. Although no specific intervention was investigated, AD improved over the study, with a decrease of PO-SCORAD and SCORAD scores from D0 to D28 by -19.19% and -24.39%, respectively. The consistency of the correlations was similar in the adult and children groups. Conclusions: This study validated the use of PO-SCORAD to self-assess AD severity and demonstrated its good correlation with SCORAD.

AB - Background: Patient-oriented medicine is an emerging concept, encouraged by the World Health Organization, to greater involvement of the patient in the management of chronic diseases. The Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) index is a self-assessment score allowing the patient to comprehensively evaluate the actual course of atopic dermatitis (AD), using subjective and objective criteria derived mainly from the SCORAD, a validated AD severity clinical assessment tool. Objectives: To validate the PO-SCORAD index in a large European population of patients exhibiting all forms of AD severity by assessing its correlation with the SCORAD index. Patients/methods: Four hundred and seventy-one patients (185 adults, 286 children) consulting for AD in hospitals from 9 European countries were recruited. The investigators and the patients used the SCORAD and PO-SCORAD scales, respectively, to assess AD severity at inclusion (D0) and 28 ± 7 days later (D28). Results: Patient-Oriented SCORing Atopic Dermatitis and SCORAD scores were significantly correlated at D0 [r = 0.67 (95% CI: 0.62; 0.72), P <0.0001]. Consistency was confirmed at D28, with a stronger linear correlation between both scales [r = 0.79 (95% CI: 0.75; 0.83), P <0.0001]. Absolute changes from baseline in SCORAD and PO-SCORAD scores were also significantly correlated [r= 0.71 (95% CI: 0.64; 0.76), P <0.0001]. Although no specific intervention was investigated, AD improved over the study, with a decrease of PO-SCORAD and SCORAD scores from D0 to D28 by -19.19% and -24.39%, respectively. The consistency of the correlations was similar in the adult and children groups. Conclusions: This study validated the use of PO-SCORAD to self-assess AD severity and demonstrated its good correlation with SCORAD.

KW - atopic dermatitis (MesH)

KW - eczema score

KW - patient-oriented

KW - SCORing of Atopic Dermatitis index

KW - self-assessment score

UR - http://www.scopus.com/inward/record.url?scp=79959937220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959937220&partnerID=8YFLogxK

U2 - 10.1111/j.1398-9995.2011.02577.x

DO - 10.1111/j.1398-9995.2011.02577.x

M3 - Article

C2 - 21414011

AN - SCOPUS:79959937220

VL - 66

SP - 1114

EP - 1121

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 8

ER -